Table 4:

Success rates of chronic FDA targeting: cumulative neurons per target

AnimalRecording duration (d)[no. of sessions]PPTLDTDRVLPOLC
LeftRightLeftRightRight
142 [13]NUNU23 (47)
221 [5]NUNUNU
337 [12]21 (42)13 (33)17 (43)
457 [9]19 (29)8 (29)10 (18)
573 [12]1 (7)NU7 (18)
666 [10]9 (20)4 (14)10 (27)
743 [8]20 (24)22 (29)11 (32)10 (26)
839 [7]4 (6)12 (19)2 (3)4 (9)
954 [9]Kinked28 (47)31 (44)NU
1057 [9]6 (8)21 (43)3 (23)5 (13)
1134 [8]27 (42)Kinked9 (15)6 (16)
1229 [8]17 (25)19 (30)NU5 (16)
1339 [6]14 (30)7 (16)Kinked3 (8)0 (4)
SOV-dependent unit count (total unit count)159 (295)113 (198)123 (270)33 (88)0 (4)
  • Success rates of animals with simultaneous chronic recordings from multiple SWRS targets. The cells include information about which targets had FDAs as well as the number of well defined SOV-dependent and total units counted over the entire course of recordings for each axis and animal. The final row is the sum of SOV and total units over all animals in the cohort. Animals 1–6 had three FDAs, animals 7–12 had a total of four FDAs, and animal 13 had a total of five FDAs. Formatting of cells refer to the following conditions: recorded units with histologic validation that the electrodes hit the target (bold); recorded units with no histologic validation (italics); recorded activity but no units crossed the 7 SD threshold (NU). Some implanted FDAs got kinked, which prevented electrodes from driving. Sessions were continuous 24 h/7 d/week recording periods between electrode driving sessions. Recording sessions typically lasted between 5 and 7 d.